Skip Nav Destination
Issues
1 October 2009
-
Cover Image
Cover Image
In this first preclinical study, synthetic polymeric vectors based on pseudodendritic oligoamines were used for tumor-specific delivery of the sodium iodide symporter (NIS) gene after systemic delivery, resulting in a significant therapeutic effect of radioiodine in a neuroblastoma mouse model. The figure shows immunofluorescence analysis using a Ki67-specific antibody (green) and an antibody against CD31 (red, labeling blood vessels) revealing high proliferation and blood vessel density in control tumors in contrast to NIS-transduced tumors after radioiodine treatment. For further details, please see Klutz and coworkers on page 6079 in this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
CCR Translations
Statistics in Clinical Cancer Research
Molecular Pathways
Human Cancer Biology
Down-regulation of ZIP4 by RNA Interference Inhibits Pancreatic Cancer Growth and Increases the Survival of Nude Mice with Pancreatic Cancer Xenografts
Min Li; Yuqing Zhang; Uddalak Bharadwaj; Qihui (Jim) Zhai; Charlotte H. Ahern; William E. Fisher; F. Charles Brunicardi; Craig D. Logsdon; Changyi Chen; Qizhi Yao
Proinflammatory Mediators Upregulate Snail in Head and Neck Squamous Cell Carcinoma
Maie A. St. John; Mariam Dohadwala; Jie Luo; Guanyu Wang; Gina Lee; Hubert Shih; Eileen Heinrich; Kostantyn Krysan; Tonya Walser; Saswati Hazra; Li Zhu; Chi Lai; Elliot Abemayor; Michael Fishbein; David A. Elashoff; Sherven Sharma; Steven M. Dubinett
Cancer Therapy: Preclinical
Vasoactivity of AG014699, a Clinically Active Small Molecule Inhibitor of Poly(ADP-ribose) Polymerase: a Contributory Factor to Chemopotentiation In vivo?
Majid Ali; Brian A. Telfer; Cian McCrudden; Martin O'Rourke; Huw D. Thomas; Marzieh Kamjoo; Suzanne Kyle; Tracy Robson; Chris Shaw; David G. Hirst; Nicola J. Curtin; Kaye J. Williams
Antiglioma Immunological Memory in Response to Conditional Cytotoxic/Immune-Stimulatory Gene Therapy: Humoral and Cellular Immunity Lead to Tumor Regression
A.K.M. Ghulam Muhammad; Marianela Candolfi; Gwendalyn D. King; Kader Yagiz; David Foulad; Yohei Mineharu; Kurt M. Kroeger; Katherine A. Treuer; W. Stephen Nichols; Nicholas S. Sanderson; Jieping Yang; Maksim Khayznikov; Nico Van Rooijen; Pedro R. Lowenstein; Maria G. Castro
Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks
Diane Palmieri; Paul R. Lockman; Fancy C. Thomas; Emily Hua; Jeanne Herring; Elizabeth Hargrave; Matthew Johnson; Natasha Flores; Yongzhen Qian; Eleazar Vega-Valle; Kunal S. Taskar; Vinay Rudraraju; Rajendar K. Mittapalli; Julie A. Gaasch; Kaci A. Bohn; Helen R. Thorsheim; David J. Liewehr; Sean Davis; John F. Reilly; Robert Walker; Julie L. Bronder; Lionel Feigenbaum; Seth M. Steinberg; Kevin Camphausen; Paul S. Meltzer; Victoria M. Richon; Quentin R. Smith; Patricia S. Steeg
Lymph Node–Targeted Immunotherapy Mediates Potent Immunity Resulting in Regression of Isolated or Metastatic Human Papillomavirus–Transformed Tumors
Kent A. Smith; Brenna L. Meisenburg; Victor L. Tam; Robb R. Pagarigan; Raymond Wong; Diljeet K. Joea; Liz Lantzy; Mayra A. Carrillo; Todd M. Gross; Uriel M. Malyankar; Chih-Sheng Chiang; Diane M. Da Silva; Thomas M. Kündig; W. Martin Kast; Zhiyong Qiu; Adrian Bot
Imaging, Diagnosis, Prognosis
MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival
Ewy A. Mathé; Giang Huong Nguyen; Elise D. Bowman; Yiqiang Zhao; Anuradha Budhu; Aaron J. Schetter; Rosemary Braun; Mark Reimers; Kensuke Kumamoto; Duncan Hughes; Nasser K. Altorki; Alan G. Casson; Chang-Gong Liu; Xin Wei Wang; Nozomu Yanaihara; Nobutoshi Hagiwara; Andrew J. Dannenberg; Masao Miyashita; Carlo M. Croce; Curtis C. Harris
Cancer Therapy: Clinical
A Phase I Dose-Finding Study of 5-Azacytidine in Combination with Sodium Phenylbutyrate in Patients with Refractory Solid Tumors
Jianqing Lin; Jill Gilbert; Michelle A. Rudek; James A. Zwiebel; Steve Gore; Anchalee Jiemjit; Ming Zhao; Sharyn D. Baker; Richard F. Ambinder; James G. Herman; Ross C. Donehower; Michael A. Carducci
Phase II Study of Neoadjuvant Imatinib in Glioblastoma: Evaluation of Clinical and Molecular Effects of the Treatment
Evangelia Razis; Panayotis Selviaridis; Stephanos Labropoulos; Jeremy L. Norris; Mei-Jun Zhu; David D. Song; Thea Kalebic; Michael Torrens; Anna Kalogera-Fountzila; George Karkavelas; Sofia Karanastasi; Jonathan A. Fletcher; George Fountzilas
Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma
Antoni Ribas; Begoña Comin-Anduix; Bartosz Chmielowski; Jason Jalil; Pilar de la Rocha; Tara A. McCannel; Maria Teresa Ochoa; Elizabeth Seja; Arturo Villanueva; Denise K. Oseguera; Bradley R. Straatsma; Alistair J. Cochran; John A. Glaspy; Liu Hui; Francesco M. Marincola; Ena Wang; James S. Economou; Jesus Gomez-Navarro
A Phase I Study of Sunitinib plus Bevacizumab in Advanced Solid Tumors
Brian I. Rini; Jorge A. Garcia; Matthew M. Cooney; Paul Elson; Allison Tyler; Kristi Beatty; Joseph Bokar; Tarek Mekhail; R.M. Bukowski; G. Thomas Budd; Pierre Triozzi; Ernest Borden; Percy Ivy; Helen X. Chen; Afshin Dowlati; Robert Dreicer
Susceptibility and Prevention
ΔNp63 Overexpression, Alone and in Combination with Other Biomarkers, Predicts the Development of Oral Cancer in Patients with Leukoplakia
Pierre Saintigny; Adel K. El-Naggar; Vali Papadimitrakopoulou; Hening Ren; You-Hong Fan; Lei Feng; J. Jack Lee; Edward S. Kim; Waun Ki Hong; Scott M. Lippman; Li Mao
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.